India is one of the fastest growing medical device markets in the world. This presentation offers an overview of important issues such as distributor search in India, medical device regulations, registration requirements, intellectual property, and more. To view these presentation slides,... Read More
This Japan drug regulatory PowerPoint presentation covers many basic issues for international drug companies looking to gain more knowledge about the Japanese drug market. It includes information on registering ethical, biological, orphan, and generic drugs in Japan. The presentation also provides information... Read More
After a drug has been approved by the China Food and Drug Administration (CFDA), it can take another year and a half until the pharmaceutical product can actually be prescribed by a doctor. To shorten this process, some drug companies begin the... Read More
已获得中国食品药品监督管理局（CFDA）批准的药物，通常需要一年半的时间医生才可以给病人使用。为尽快让病人使用上已经批准的药物，一些制药公司开始在药物获得批准以前，就开始着手价格审批，招投标和医院上市的工作。中国的药品定价，是指医院进行的药品定价和药品采购。确定进口药品的价格与设定国产药物的价格，有所不同。 Read More
The Chinese pharmaceutical market was worth an estimated $75 billion in 2013. The market grew 20% year after year during the past decade and is projected to continue expanding at the rate of 17.5% per year through 2020. Currently the third largest... Read More
China's medical device market has grown to $13 billion, the second largest in Asia after Japan. The number of foreign medical device manufacturers registering their products in China has grown exponentially. View our webcast to learn about the new regulations in China.... Read More
Japan is the second largest medical device market in the world. Getting through the registration process and selling your product on the market is not an easy task. This webcast will focus on key steps including PMDA consultation sessions, how to maximize... Read More
China’s pharmaceutical market is booming! The market is growing almost 15% annually and is expected to be about $100 billion dollars in 2017. However, drug regulations are complicated in China. In addition, once your drug is approved, what needs to be done... Read More
On October 1, Korea’s National Health Insurance Corporation expanded its coverage to include ultrasound scans for patients suffering from one of the so-called “four major diseases”: cancer, heart disease, cerebrovascular diseases and rare or incurable diseases. Under the new scheme, more than... Read More
The medical device market in Hong Kong reached about $850 million in 2012, and it is expected to grow at an annual rate of 8.5 percent for the next five years. This is a good sized market, considering Hong Kong's small population... Read More